162 related articles for article (PubMed ID: 3962178)
41. Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months.
Techasena W; Sriprasert P; Pattamadilok S; Wongwacharapipoon P
J Med Assoc Thai; 2007 Jan; 90(1):106-12. PubMed ID: 17621740
[TBL] [Abstract][Full Text] [Related]
42. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel.
Dagan R; Slater PE; Duvdevani P; Golubev N; Mendelson E
Pediatr Infect Dis J; 1995 Nov; 14(11):965-9. PubMed ID: 8584363
[TBL] [Abstract][Full Text] [Related]
43. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
Rogers S; Sanders RC; Alpers MP
J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293
[TBL] [Abstract][Full Text] [Related]
44. Kinetics of measles antibody by hemagglutination inhibition assay in children in south-west and north-central Nigeria.
Onoja AB; Adeniji AJ
Int J Infect Dis; 2013 Jul; 17(7):e552-5. PubMed ID: 23510540
[TBL] [Abstract][Full Text] [Related]
45. Measles active and passive immunity in a worldwide perspective.
Black FL
Prog Med Virol; 1989; 36():1-33. PubMed ID: 2685909
[TBL] [Abstract][Full Text] [Related]
46. Humoral and cellular immune response after measles vaccination in Taiwan.
Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
[TBL] [Abstract][Full Text] [Related]
47. Optimum age of measles immunization--maternal and transplacentally transmitted measles antibodies in infancy.
Mohan M; Mehta PK; Sehgal S; Prabhakar AK; Bhargava SK
Indian Pediatr; 1981 Sep; 18(9):631-5. PubMed ID: 7319611
[No Abstract] [Full Text] [Related]
48. [Immunologic response and post-vaccination reactions in children vaccinated against measles. II. Antibody levels and seroconversion following vaccination].
Kańtoch M; Naruszewicz-Lesiuk D; Polna I; Lityńska J
Przegl Epidemiol; 1974; 28(3):325-31. PubMed ID: 4471838
[No Abstract] [Full Text] [Related]
49. A comparison of alternate immunization regimes for measles in vaccinated populations.
Pabst HF; Boothe PM; Carson MM
Vaccine; 1999 Jan; 17(2):182-92. PubMed ID: 9987153
[TBL] [Abstract][Full Text] [Related]
50. The duration of maternal measles antibodies in children.
Kiliç A; Altinkaynak S; Ertekin V; Inandi T
J Trop Pediatr; 2003 Oct; 49(5):302-5. PubMed ID: 14604165
[TBL] [Abstract][Full Text] [Related]
51. Maintaining high rates of measles immunization in Africa.
Lessler J; Moss WJ; Lowther SA; Cummings DA
Epidemiol Infect; 2011 Jul; 139(7):1039-49. PubMed ID: 20920382
[TBL] [Abstract][Full Text] [Related]
52. [Measles: optimum age and number of doses recommended for vaccination in Brazil].
Soerensen B; Takeda AK; Nakandakare IK; Curi Lde C; Umekita LF; Zuccas WA; Guidoni R; Magalhães E; Britto SS; Feijó EI
Rev Inst Med Trop Sao Paulo; 1985; 27(2):55-65. PubMed ID: 4089457
[No Abstract] [Full Text] [Related]
53. Maternally derived measles immunity in children of naturally infected and vaccinated mothers.
Jenks PJ; Caul EO; Roome AP
Epidemiol Infect; 1988 Oct; 101(2):473-6. PubMed ID: 3053223
[TBL] [Abstract][Full Text] [Related]
54. The influence of maternally derived antibody on the efficacy of further attenuated measles vaccine.
Stewien KE; Barbosa V; de Lima OS; Osiro K
Infection; 1978; 6(5):207-10. PubMed ID: 730390
[TBL] [Abstract][Full Text] [Related]
55. Loss maternally derived measles immunity in Argentinian infants.
Nates SV; Giordano MO; Medeot SI; Martínez LC; Baudagna AM; Naretto E; Garrido P; De Wolff CD
Pediatr Infect Dis J; 1998 Apr; 17(4):313-6. PubMed ID: 9576386
[TBL] [Abstract][Full Text] [Related]
56. The levels of measles antibodies in Nigerian children aged 0-12 months and its relationship with maternal parity.
Eghafona NO; Ahmad AA; Odama LE; Onuora C; Gosham LT; Emejuaiwe SO; Woghiren EI
Epidemiol Infect; 1987 Oct; 99(2):547-50. PubMed ID: 3678407
[TBL] [Abstract][Full Text] [Related]
57. Effect of early measles vaccination (AIK-C strain) for preterm infants.
Ichikawa T; Tsuji A; Fujino M; Kusano R; Sugiyama R; Oomori S; Mori K; Maeyama K; Nakayama T
Pediatr Int; 2013 Apr; 55(2):163-8. PubMed ID: 23379893
[TBL] [Abstract][Full Text] [Related]
58. Seroconversion after administration of measles vaccine to central Australian Aboriginal children at nine months of age.
Hanna JN; Macintyre AB; Worswick DA; Burrell CJ
Med J Aust; 1989 Feb; 150(4):188, 191-2. PubMed ID: 2654583
[TBL] [Abstract][Full Text] [Related]
59. Maternally derived measles immunity in era of vaccine-protected mothers.
Lennon JL; Black FL
J Pediatr; 1986 May; 108(5 Pt 1):671-6. PubMed ID: 3701511
[TBL] [Abstract][Full Text] [Related]
60. Evidence for reinstatement of infants 12 to 14 months of age into routine measles immunization programs.
Wilkins J; Wehrle PF
Am J Dis Child; 1978 Feb; 132(2):164-6. PubMed ID: 626182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
